Pfizer/BioNTech Covid-19 vaccine highly protective in 12-18 age group: US CDC study

The Pfizer Inc/BioNTech SE Covid-19 vaccine was 93 per cent effective in preventing hospitalisations among those aged 12 to 18, according to an analysis released by the United States Centers for Disease Control and Prevention (CDC) on Tuesday.

from US News Headlines, Latest USA News, US news live on Times of India https://ift.tt/3lVcKJt
via IFTTT